Using machine learning approaches for multi-omics data analysis: A review

PS Reel, S Reel, E Pearson, E Trucco… - Biotechnology advances, 2021 - Elsevier
With the development of modern high-throughput omic measurement platforms, it has
become essential for biomedical studies to undertake an integrative (combined) approach to …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

[PDF][PDF] Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

B Williams, G Mancia, W Spiering, E Agabiti Rosei… - Rev Esp …, 2019 - peroxfarma.com
La tarea de elaboración de GPC incluye la creación de herramientas educativas y
programas de implementación de las recomendaciones. Para su implementación, se …

Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión-Liga Española para la Lucha contra …

M Gorostidi, T Gijón-Conde, A De la Sierra… - Hipertensión y riesgo …, 2022 - Elsevier
La hipertensión arterial es el principal factor de riesgo de enfermedad y muerte en España.
El diagnóstico y el tratamiento de la hipertensión arterial constituyen objetivos básicos de …

Hypertension, a moving target in COVID-19: current views and perspectives

C Savoia, M Volpe, R Kreutz - Circulation Research, 2021 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …

2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - … of Hypertension of …, 2019 - taylorfrancis.com
Guidelines summarize and evaluate available evidence with the aim of assisting health
professionals in selecting the best management strategies for an individual patient with a …

[HTML][HTML] Precision medicine and the future of cardiovascular diseases: a clinically oriented comprehensive review

Y Sethi, N Patel, N Kaka, O Kaiwan, J Kar… - Journal of clinical …, 2023 - mdpi.com
Cardiac diseases form the lion's share of the global disease burden, owing to the paradigm
shift to non-infectious diseases from infectious ones. The prevalence of CVDs has nearly …

[HTML][HTML] Rationale and design of the Medical Research Council's precision medicine with Zibotentan in microvascular angina (PRIZE) trial

AJ Morrow, TJ Ford, K Mangion, T Kotecha… - American Heart …, 2020 - Elsevier
Background Microvascular angina is caused by cardiac small vessel disease, and
dysregulation of the endothelin system is implicated. The minor G allele of the non-coding …

Understanding the role of genetics in hypertension

RS Patel, S Masi, S Taddei - European heart journal, 2017 - academic.oup.com
Hypertension is a major modifiable risk factor for renal, cardiovascular, and cerebrovascular
disease, and a leading underlying cause of global mortality and morbidity. 1 Incremental …

Precision medicine and personalized medicine in cardiovascular disease

G Currie, C Delles - Sex-Specific Analysis of Cardiovascular Function, 2018 - Springer
Precision medicine aims to offer “the right treatment to the right patient at the right time.” In
cardiovascular medicine the potential of precision medicine applies to all stages of the …